July 24th 2024
A new analysis by researchers at the National Institutes of Health shows the benefit of taking AREDS2 formula in late AMD.
Pegcetacoplan shows increasing beneficial effects after 30 months of continuous treatment for GA
August 2nd 2023Data from the 30 month GALE extension study indicated that continuous treatment with pegcetacoplan injection showed increasing beneficial effects over that timeframe in patients with geographic atrophy (GA).